Method and apparatus for enzymatic synthesis of polynucleotides
AssigneeDNA Script
InventorsAdrian Horgan, Xavier Godron
Life of this patent
Estimating the term…
Abstract
The invention is directed to methods and apparatus for parallel enzymatic synthesis of polynucleotides in an array of reaction chambers using a template-free polymerase that has sequence-dependent coupling efficiencies. Whenever sequences causing low efficiency coupling occur at a 3′ end of a growing chain of a polynucleotide being synthesized, one or more additional coupling cycles without de-protection steps are inserted into synthesis plans to provide additional time for completing the coupling reaction at that position of the polynucleotide.
Claims9
A method for synthesizing with a template-free polymerase a plurality of polynucleotides each with a predetermined sequence, wherein the template-free polymerase has reduced coupling efficiency at one or more inefficiency motifs, the method comprising the steps of:
- (a) providing a reaction chamber for each polynucleotide of the plurality of polynucleotides, each reaction chamber having disposed therein a synthesis support with initiators attached, wherein each initiator has a free 3′-hydroxyl, and wherein each reaction chamber has an inlet and an outlet and a filter that retains the synthesis support and that is operationally associated with the outlet so that reaction solutions exiting the reaction chamber pass through the filter;
- (b) providing a waste manifold operationally associated with the outlets of the reaction chambers so that whenever a positive pressure differential is created between the reaction chambers and the waste manifold, reaction solutions are removed from the reaction chambers;
- (c) repeating for each reaction chamber, until a polynucleotide of such reaction chamber is complete, cycles of the following reaction steps:
- (i) contacting in a coupling solution the initiator or a deprotected elongated fragment with a 3′-protected nucleoside triphosphate and a template-free polymerase so that the initiator or the deprotected elongated fragment is elongated by the 3′-protected nucleoside triphosphate to form a 3′-protected elongated fragment,
- (ii) deprotecting the 3′-protected elongated fragment with a deprotection solution, and
- (iii) applying a pressure differential between the reaction chambers and the waste manifold to remove reaction solution(s) from the reaction chambers;
- wherein the kind of 3′-protected nucleoside triphosphate contacted in step (i) in a reaction chamber is determined by the predetermined sequence of the reaction chamber, and
- wherein, prior to each cycle, one or more short cycles of step (i) is carried out in a reaction chamber whenever an inefficiency motif is present at a 3′ end of the deprotected elongated fragment of such reaction chamber, wherein the inefficiency motif is CCA, CTA, GCA, GTA or CCT.
Dependencies are inferred from the claim text.